Angela Lam

Title: Angela Lam: Innovator in HCV Treatment

Introduction

Angela Lam is a notable inventor based in Fort Lee, NJ (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). Her innovative work has led to the development of new compounds that hold promise for effective antiviral therapies.

Latest Patents

Angela Lam holds a patent for 4-ethynyl pyrazole derivative compounds and methods for the treatment of HCV. This patent includes aryl substituted pyrazole derivatives and outlines processes for their preparation. The invention also provides compositions and methods for treating HCV by administering a compound of the present invention, either alone or in combination with additional antiviral agents, in a therapeutically effective amount. She has 1 patent to her name.

Career Highlights

Angela has established herself as a key figure in the biopharmaceutical industry. Her work at XTL Biopharmaceuticals Ltd. has been instrumental in advancing research and development in antiviral treatments. Her dedication to innovation has positioned her as a leader in her field.

Collaborations

Angela collaborates with talented professionals in her field, including Guolin Li and Reza Fathi. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Angela Lam's contributions to the treatment of HCV through her innovative compounds and methods highlight her role as a significant inventor in the biopharmaceutical sector. Her work continues to pave the way for advancements in antiviral therapies.